SeaPet 2019-2022

SeaPET: Development of seaweed-based bioactive ingredients for pet supplement
Partnership: ISS, CIIMAR, IPMA, Zu, Barkyn, WePharm, 11Pets

    Responsible:
    Funding Entity:
    Reference:
    Funding Total:
    Duration:

Objective:

Development of bioactive compounds derived from seaweed with bioactivity characteristic for natural pet supplement production.